Immediate Impact

3 by Nobel laureates 3 from Science/Nature 58 standout
Sub-graph 1 of 21

Citing Papers

A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
2024 Standout
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
2023 Standout
2 intermediate papers

Works of Claudia Crippa being referenced

Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse
2020
Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma
2010

Author Peers

Author Last Decade Papers Cites
Claudia Crippa 787 499 712 46 949
Luděk Pour 756 489 747 64 1.0k
Anita Zahlten‐Kumeli 798 529 689 24 951
Tommasina Guglielmelli 692 429 571 29 856
Kelly Godby 661 418 476 52 748
Sonia Ronconi 818 469 561 36 1.0k
Patrick Jedlowski 426 233 514 33 763
Johannes C. Kirchheimer 481 303 286 41 1.1k
Harousseau Jl 593 291 339 42 743
G. Ucci 459 353 353 61 921
Bin Wu 328 321 468 38 989

All Works

Loading papers...

Rankless by CCL
2026